This 21-marker panel checks liver, kidney, lipid and blood sugar markers alongside lipase, aimed at people taking Tirzepatide (sold as Mounjaro or Zepbound) who want to monitor how their body is responding to the medication.
21 biomarkers as listed by Blue Horizon Medicals.
This panel is built around monitoring people taking Tirzepatide (the active ingredient in Mounjaro and Zepbound), rather than a general health check. It covers kidney markers (sodium, urea, chloride, eGFR, creatinine), liver markers (total protein, albumin, globulin, ALP, ALT, AST, GGT, bilirubin), a lipid profile, HbA1c for blood sugar, and lipase, which is produced by the pancreas. These are the kinds of markers a clinician would typically look at to keep an eye on how the body is adjusting to this type of medication.
With 21 biomarkers, it scores well for clinical depth, sitting in the upper quarter of the metabolism tests we track. On price it is close to the middle of the pack for panels of this size, only a few pounds above the median. Where it scores less well is collection convenience, because it needs a venous blood draw at a clinic rather than offering an at-home option, though a nurse home visit is available; turnaround is around five days.
Clarity and documentation score highly because the listing sets out in detail what is measured and why, though it does not describe the report format. Results are reviewed by a doctor, and the trust-signal score reflects Blue Horizon Medicals' 4.2 Trustpilot rating from 395 reviews, its UKAS-accredited partner labs, and more than 17 years trading.
This is aimed specifically at people currently prescribed Tirzepatide, whether for type 2 diabetes or weight management, who want to keep track of liver, kidney, lipid and blood sugar markers over the course of treatment. The provider suggests a baseline test before starting and a re-check every three months or after a dose increase. If you are taking semaglutide (Ozempic) instead, Blue Horizon's separate Ozempic Monitoring Blood Test covers the same 21 markers and is the more relevant choice. If you are not on either medication, a general metabolic or organ-health panel not built around a specific drug would likely suit you better.
A sample is taken by venous blood draw, either at a clinic or during a nurse home visit; there is no at-home finger-prick option for this test. Once the sample reaches the lab it is processed and a doctor reviews the results before your report is issued, which typically takes around five days from collection.
The Mounjaro Monitoring Blood Test checks 21 liver, kidney, lipid, protein and pancreas markers alongside HbA1c for £129.75, aimed at people taking Tirzepatide. It is priced close to the median for similarly sized metabolism panels we track, and its main limitation is that it requires a venous blood draw at a clinic or nurse visit rather than an at-home finger-prick, with results taking around five days.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
21 biomarkers, placing it in the 78th percentile of metabolism tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£129.75 against a median of £124.38 for the 14 similarly sized metabolism tests we track (+4%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
21-marker Dulaglutide monitoring panel
A 21-marker blood panel that checks kidney function, liver function, cholesterol, blood sugar (HbA1c) and pancreas health, aimed at people taking the GLP-1 medication Dulaglutide (Trulicity). Suits ongoing monitoring rather than a first general health check.
21-marker monitoring panel for Saxenda users
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking daily injectable liraglutide (Saxenda) who want to monitor how their body is responding over time.
